Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-28 Option Award | 2023-06-29 09:00 am | N/A 2033-06-28 | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2022-10-13 Option Award | 2022-10-17 4:45 pm | N/A 2032-10-13 | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2022-05-06 Exercise | 2022-05-10 6:04 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner | 135,183 | $1.46 | 3,202,430 (Direct) | View |
| 2022-05-06 Tax Withholding | 2022-05-10 6:04 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner | 54,074 | $3.65 | 3,202,430 (Direct) | View |
| 2022-05-06 Exercise | 2022-05-10 6:04 pm | N/A 2028-08-17 | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner | 135,183 | $0 | 3,202,430 (Direct) | View |
| 2021-07-29 Conversion | 2021-08-02 8:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer | 560,656 | $0 | 3,090,865 (Direct) | View |
Ownership | 2021-07-26 9:21 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer | 0 | $0 | 3,179,787 (Direct) | View |